首页 > 化工企业 > MedChemexpress > N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid
MedChemexpress

货号: HY-16582

N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid

  • 1218778-77-8
  • C26H32F3N3O11P2
  • 98%
  • 7日

销 售 价 ¥930.00 /mg

选择规格
  • 5mg
全部
最小起订
1mg
支付方式
e商贷 摩易付

摩贝商家

商家名称
MedChemexpress
所在地区
美国 新泽西 纽瓦克
公司电话
609-2286898
联系手机
18019480960
认证属性
试剂

店内搜索

热销产品

perampanel

(380917-97-5)

¥1540

盐酸纳曲酮

(16676-29-2)

¥400

唑吡坦

(82626-48-0)

¥1023

地西泮

(439-14-5)

¥930

普瑞巴林

(148553-50-8)

¥550

  • 商品详情
  • 商品评价
  • MSDS
信息更新时间:2018.06.10
  • N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid
  • 98%
  • 5mg
  • 1 mg
  • 7日
  • HY-16582
化合物信息 [查看化合物百科]
化合物英文学名 N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid 化合物中文学名 Sonidegib phosphate
CAS号 1218778-77-8 分子式 C26H32F3N3O11P2
分子量 681.489 精确质量 681.146
LogP 4.4133 PSA 242.32
详细描述
产品描述:LDE225 Diphosphate (NVP-LDE225; Erismodegib) is a Smoothened (Smo) antagonist, inhibiting Hedgehog (Hh) signaling with IC50 of 1.3 nM (mouse) and 2.5 nM (human), respectively. IC50 value: 1.3 nM/2.5 nM (Hh signaling Mouse/Human) [1] Target: Smoothened in vitro: LDE225 inhibits TM3 luciferized cell line with 0.6 nM and 8 nM, at the presence of 1 nM and 25 nM Hh agonist Ag1.5, respectively [1]. in vivo: LDE225 is highly bound to mouse, rat, and human plasma proteins (>99%) and moderately bound to dog and monkey plasma proteins (77 and 85%, respectively). LDE225 has high permeability (90.8% in man) in the PAMPA assay. LDE225 shows good oral bioavailability ranging from 69 to 102% in preclinical species when dosed in solution. LDE225 is a weak base with a measured pKa of 4.20 and exhibits relatively poor aqueous solubility. LDE225 demonstrates dose-related antitumor activity. At a dose of 5 mg/kg/day qd, LDE225 significantly inhibits tumor growth, corresponding to a T/C value of 33%. When dosed at 10 and 20 mg/kg/day qd, LDE225 gives rise to 51 and 83% regression, respectively. Gli1 mRNA inhibition correlates with tumor and plasma exposure of LDE225. LDE225 successfully penetrates the blood?brain barrier in tumor-bearing animals and results in tumor growth inhibition after 4 days of treatment [1]. LDE225 significantly reduces the tumor volume by 95.7% in Rip1-Tag2 mice. LDE225 prolongs survival in Rip1Tag2 mice. LDE225 decreases expression of stromal markers in the LDE225-treated mice [2].
产品链接:http://www.medchemexpress.com/Gabapentin-enacarbil.html
产品链接:http://www.medchemexpress.cn/lde225-diphosphate.html

该公司尚未提供产品的MSDS报告,下部信息为摩贝百科数据库为您提供的MSDS信息,供您参考。

提醒该企业完善MSDS信息
MSDS

采购信息

N-[6-[(2S,6R)-2,6-dimethylmorpholin-4-yl]pyridin-3-yl]-2-methyl-3-[4-(trifluoromethoxy)phenyl]benzamide,phosphoric acid

1218778-77-8

*
*
*
*
*
 
 
 

购物车 0

不要让您的购物车空着哦,买试剂买原料
如果您已添加过宝贝,那就赶紧登录查看吧

投诉建议

  • 咨询类别
  • 问题描述
  • 联系人电话
  • 联系人

化工圈APP

二维码

微信公众号

二维码